Desire; Laurent

Patent Applications and Registrations

Patent applications and USPTO patent grants for Desire; Laurent.The latest application filed is for "substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde 10a)".

Company Profile

0.9.19

Desire; Laurent - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) Grant 9,902,710 - Leblond , et al. February 27, 2	2018-02-27
Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) Grant 9,670,181 - Leblond , et al. June 6, 2	2017-06-06
DYRK1 inhibitors and uses thereof Grant 9,446,044 - Leblond , et al. September 20, 2	2016-09-20
Substituted 6, 7-dialkoxy-3-isoquinoline Derivatives As Inhibitors Of Phosphodiesterase 10 (pde 10a) App 20160264549 - Leblond; Bertrand ; et al.	2016-09-15
Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) Grant 9,200,016 - Leblond , et al. December 1, 2	2015-12-01
Substituted 6, 7-dialkoxy-3-isoquinoline Derivatives As Inhibitors Of Phosphodiesterase 10 (pde 10a) App 20150158895 - Leblond; Bertrand ; et al.	2015-06-11
Substituted 6,7-dialkoxy-3-isoquinolinol Derivatives As Inhibitors Of Phosphodiesterase 10 (pde 10a) App 20140309253 - Leblond; Bertrand ; et al.	2014-10-16
Dyrk1 Inhibitors And Uses Thereof App 20140275064 - Leblond; Bertrand ; et al.	2014-09-18
Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A) Grant 8,772,316 - Leblond , et al. July 8, 2	2014-07-08
Substituted Isoquinolines And Their Use As Tubulin Polymerization Inhibitors App 20130131018 - Leblond; Bertrand ; et al.	2013-05-23
Methods For Treating Diseases Of The Retina App 20120214842 - Donello; John E. ; et al.	2012-08-23
Substituted 6,7-dialkoxy-3-isoquinolinol Derivatives As Inhibitors Of Phosphodiesterase 10 (pde10a) App 20120214837 - Leblond; Bertrand ; et al.	2012-08-23
Methods involving PDE4, compositions, and the screening thereof, for the treatment of degenerative ocular pathologies Grant 7,872,015 - Schweighoffer , et al. January 18, 2	2011-01-18
Bace455, An Alternative Splice Variant Of The Human Beta-secretase App 20100317830 - DESIRE; LAURENT	2010-12-16
Antibody to BACE455, an alternative splice variant of the human beta-secretase Grant 7,790,864 - Desire September 7, 2	2010-09-07
Methods and Tools for The Therapy of Neurodegenerative Pathologies App 20090317842 - Schweighoffer; Fabien ; et al.	2009-12-24
Methods of Treating Degenerative Disorders With Rac 1B Inhibitor App 20090285820 - Desire; Laurent ; et al.	2009-11-19
Compounds and methods for treatment of amyloid-beta-peptide related disorders App 20090118282 - Leblond; Bertrand ; et al.	2009-05-07
Methods of Treating Nervous Disorders App 20090093471 - Desire; Laurent ; et al.	2009-04-09
Compounds Which Inhibits Protein Prenylation E.G. Geranylgeransferse or Farnesyltransferase Inhibitors for Treating Parkinson's Disease App 20080153758 - Schweighoffer; Fabien ; et al.	2008-06-26
Bace455, an alternative splice variant of the human beta-secretase App 20070142277 - Desire; Laurent	2007-06-21
Methods of treating nervous disorders App 20070027146 - Desire; Laurent ; et al.	2007-02-01
Method involving pde4, compositions, and the screening thereof, for the treatment of degenerative ocular pathologies App 20060241062 - Schweighoffer; Fabien ; et al.	2006-10-26
Use of pyrazolopyridines for the treatment of cognitive deficits App 20060142326 - Schweighoffer; Fabien ; et al.	2006-06-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.